نتایج جستجو برای: cish

تعداد نتایج: 728  

Journal: :Anticancer research 2004
Nadia Dandachi Otto Dietze Cornelia Hauser-Kronberger

BACKGROUND The purpose of this study was to assess the clinical relevance of HER2 amplification by a novel chromogenic in situ hybridisation (CISH) technique in patients with primary breast cancer and to determine its relationship with other prognostic markers. MATERIALS AND METHODS One hundred and seventy-three breast cancer patients with a mean follow-up duration of 75 months were reanalyse...

2004
M T Sandinha M A Farquharson F Roberts

Background/aims: In uveal melanoma monosomy 3 is emerging as a significant indicator of a poor prognosis. To date most cytogenetic studies of uveal melanoma have utilised fresh tissue or DNA extracted from tissue sections. In this study chromosome in situ hybridisation (CISH) was used to study monosomy 3 in tissue sections. The copy number of chromosome 3 was determined and related to patient s...

2017
Basim Mohammed Khashman Safana Abdul-Sattar

Background: Breast cancer is the most common malignancy among women worldwide.The human epidermal growth factor receptor (HER) is a transmembrane receptor in the epidermal growth factor (EGF) receptor family located at the long arm of human chromosome 17 (17q12). Diagnostic assays for HER2 in breast cancer provide important prognostic information and independently help guide management by ident...

2017
Hugo N. Humphries Susrutha K. Wickremesekera Reginald W. Marsh Helen D. Brasch Shreeja Mehrotra Swee T. Tan Tinte Itinteang

Background Fifty percent of colorectal cancer (CRC) patients develop liver metastasis. This study identified and characterized cancer stem cells (CSCs) within colon adenocarcinoma metastasis to the liver (CAML). Methods 3,3-Diaminobenzidine immunohistochemical (IHC) staining was performed on nine CAML samples for embryonic stem cell (ESC) markers OCT4, SOX2, NANOG, c-Myc, and KLF4. Immunofluo...

Journal: :Molecular cancer therapeutics 2007
Lorenzo Daniele Luigia Macrì Marina Schena Diego Dongiovanni Lisa Bonello Enrico Armando Libero Ciuffreda Oscar Bertetto Gianni Bussolati Anna Sapino

In non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) mutational analysis is an excellent predictor of responsiveness to treatment with tyrosine kinase inhibitors, such as gefitinib. In up to 80% of NSCLCs, cytologic samples or endoscopic biopsies are the only specimens available for molecular analysis, but PCR amplification of DNA from small fixed and paraffin-embedded...

Journal: :Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2014
Heraklis Moreas Evangelos Tsiambas Andreas C Lazaris Afrodite Nonni Andreas Karameris George E Metaxas Hilianna E Armatas Efstratios Patsouris

PURPOSE Human papillomaviruses (HPV)-mediated cervical carcinogenesis represents a well analyzed model of viral implication in epithelial malignant transformation. Concerning colorectal cancer, HPV infection seems to be a significant genetic event in squamous colon epithelia carcinogenesis, but with an unclear role in colon adenocarcinomas (CACs). In the current study, we analyzed 60 CACs based...

Journal: :The British journal of ophthalmology 2004
M T Sandinha M A Farquharson F Roberts

BACKGROUND/AIMS In uveal melanoma monosomy 3 is emerging as a significant indicator of a poor prognosis. To date most cytogenetic studies of uveal melanoma have utilised fresh tissue or DNA extracted from tissue sections. In this study chromosome in situ hybridisation (CISH) was used to study monosomy 3 in tissue sections. The copy number of chromosome 3 was determined and related to patient su...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2007
J Bergqvist J F Ohd J Smeds S Klaar J Isola H Nordgren G P Elmberger H Hellborg J Bjohle A-L Borg L Skoog J Bergh

BACKGROUND Our aim was to use quantitative real-time PCR (Q-PCR) and RNA expression profiles (RNA-EPs) to investigate HER2 status in relation to outcome. PATIENTS AND METHODS Cut-off levels for Q-PCR and RNA-EP were established in relation to immunohistochemistry (IHC) validated by FISH in a test set of frozen tissue samples from 40 primary breast cancers. The HER2 status was subsequently stu...

ژورنال: :مجله دانشکده پزشکی دانشگاه علوم پزشکی تهران 0
فرید کوثری kosari f گروه پاتولوژی، بیمارستان سینا، دانشگاه علوم پزشکی تهران حمیدرضا یاریگر روش yarigarravesh hr گروه پاتولوژی، بیمارستان سینا، دانشگاه علوم پزشکی تهران ملیحه رضوان rezvan m گروه علوم آزمایشگاهی، بیمارستان آتیه،

زمینه و هدف: لنفوم منتشر سلول های بزرگ b شایع ترین نوع از لنفوم های غیرهوچکینی می باشد. نقش ویروس ابشتین بار در ایجاد این لنفوم شناخته شده است. این مطالعه قصد دارد تا میزان همراهی ویروس ابشتین بار را با لنفوم منتشر سلول های بزرگ b به روش chromogenic in situ hybridization (cish) در بیماران بخش پاتولوژی بیمارستان های شریعتی و سینا در سال های ١٣٨6-١٣٨4 مورد بررسی قرار دهد. روش بررسی: این مطالعه به...

Journal: :American journal of clinical pathology 2009
Frédérique Penault-Llorca Michael Bilous Mitch Dowsett Wedad Hanna Robert Yoshiyuki Osamura Josef Rüschoff Marc van de Vijver

Patients with human epidermal growth factor receptor-2 (HER2)+ breast cancer are eligible for trastuzumab treatment; therefore, accurate assessment of HER2 status is essential. Until recently, only 2 methods were validated for determining the HER2 status of breast tumors in the routine diagnostic setting: immunohistochemical analysis and fluorescence in situ hybridization (FISH). Recently, brig...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید